Skip to main content
. 2023 Jan 17;16:3. doi: 10.1186/s13045-022-01397-y

Fig. 3.

Fig. 3

Structure of antibody–drug conjugates that have reach clinical trials and their payloads (blue) classified regarding their mechanism of action. Notations within the figure: [ADC name], antibody, payload